{"id":"https://openalex.org/W1223908403","doi":null,"title":"Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.","display_name":"Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W1223908403","mag":"1223908403","pmid":"https://pubmed.ncbi.nlm.nih.gov/10405643"},"language":"en","primary_location":{"id":"pmid:10405643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10405643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W1223908403"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006459642","display_name":"Akihiro Tomida","orcid":"https://orcid.org/0009-0000-1394-7293","observed_orcids":["https://orcid.org/0009-0000-1394-7293"]},"institutions":[{"id":"https://openalex.org/I4405286657","display_name":"Institute for Quantitative Biosciences, The University of Tokyo","ror":"https://ror.org/02qwvne14","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286657","https://openalex.org/I74801974"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"A Tomida","raw_affiliation_strings":["Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan","institution_ids":["https://openalex.org/I4405286657","https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112158124","display_name":"Takashi TSURUO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Tsuruo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5172,"has_fulltext":false,"cited_by_count":165,"citation_normalized_percentile":{"value":0.89612591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"14","issue":"2","first_page":"169","last_page":"177"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.024900000542402267,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7400000095367432},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cellular-stress-response","display_name":"cellular stress response","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8389999866485596},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.8339999914169312},{"id":"https://openalex.org/keywords/tumor-acidosis","display_name":"tumor acidosis","score":0.5929999947547913},{"id":"https://openalex.org/keywords/glucose-deprivation","display_name":"glucose deprivation","score":0.6140000224113464},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.8119999766349792},{"id":"https://openalex.org/keywords/topoisomerase-ii-alpha","display_name":"TOP2A","score":0.9229999780654907},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.7369999885559082},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.996999979019165},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cisplatin-sensitivity","display_name":"cisplatin sensitivity","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.820476770401001},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6698125600814819},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.6471211910247803},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5896662473678589},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5647906064987183},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5598853826522827},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5373436808586121},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5275080800056458},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4970102608203888},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4563463628292084},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.45591577887535095},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4417245090007782},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.438043475151062},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3843643367290497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3631434440612793},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.36283183097839355},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.33002275228500366},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31692707538604736},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26842835545539856},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14196747541427612},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.12571728229522705},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.11374953389167786},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10345837473869324},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015687","descriptor_name":"Cell Hypoxia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10405643","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10405643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drug design","raw_type":"Journal Article"},{"id":"mag:1223908403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10405643","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2399958038","https://openalex.org/W2243947017","https://openalex.org/W1561786195","https://openalex.org/W996255292","https://openalex.org/W3040856544","https://openalex.org/W2401719389","https://openalex.org/W2478768451","https://openalex.org/W1507488943","https://openalex.org/W2094844488","https://openalex.org/W370878613"],"abstract_inverted_index":{"Most":[0],"solid":[1,19,165,182,200],"tumors":[2,22],"show":[3],"resistance":[4,10,67,82,97,139,198],"to":[5,64,68,140,156,171,194],"current":[6],"chemotherapy.":[7],"This":[8,78],"drug":[9,81,96,149,197],"can":[11,98],"be":[12,99,175],"associated":[13],"with":[14],"the":[15,49,60,107,128,138,148,160,178,196],"unique":[16,192],"physiology":[17],"of":[18,26,35,53,66,80,95,131,159,186,199],"tumors.":[20,183,201],"Solid":[21],"generally":[23],"have":[24],"regions":[25],"low":[27,30,33],"oxygen":[28],"(hypoxia),":[29],"pH":[31],"and":[32,76,85],"levels":[34],"glucose,":[36],"which":[37],"are":[38,91,117,144],"not":[39],"observed":[40],"in":[41,110,147],"normal":[42],"tissues.":[43],"These":[44],"tumor-specific":[45],"conditions":[46,90],"commonly":[47],"cause":[48],"glucose-regulated":[50],"stress":[51,61,89],"response":[52,62],"cancer":[54],"cells.":[55,123],"Accumulating":[56],"evidence":[57],"shows":[58],"that":[59,168],"leads":[63],"induction":[65,94],"multiple":[69],"drugs,":[70],"such":[71,126],"as":[72,127],"etoposide,":[73],"doxorubicin,":[74],"camptothecin":[75],"vincristine.":[77],"type":[79],"is":[83],"reversible":[84],"decays":[86],"rapidly":[87,121],"when":[88],"removed.":[92],"The":[93],"partly":[100],"explained":[101],"by":[102],"cell":[103],"cycle":[104],"arrest":[105],"at":[106],"G1":[108],"phase":[109],"stressed":[111,172,187],"cells":[112,173,188],"because":[113],"most":[114,161],"anticancer":[115],"drugs":[116,163],"primarily":[118],"effective":[119,162],"against":[120,164,181],"dividing":[122],"Specific":[124],"mechanisms,":[125],"decreased":[129],"expression":[130],"DNA":[132],"topoisomerase":[133],"(topo)":[134],"II":[135,142],"alpha":[136],"for":[137,177],"topo":[141],"poisons,":[143],"also":[145],"involved":[146],"resistance.":[150],"Stressed":[151],"cells,":[152],"however,":[153],"become":[154],"hypersensitive":[155],"cisplatin,":[157],"one":[158],"tumors,":[166],"suggesting":[167],"preferential":[169],"cytotoxicity":[170],"may":[174],"important":[176],"clinical":[179],"efficacy":[180],"Further":[184],"characterization":[185],"will":[189],"provide":[190],"a":[191],"target":[193],"circumvent":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1223908403","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
